Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB

NCT05063110 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Adults Patients Having Non Severe HLH

Interventions

DRUG: Itacitinib

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]